Pacegenix, Inc.

Biotech Cambridge, MA

About

Issuer

Entity type
Corporation
Jurisdiction
Delaware
Sector
Biotech
Headquarters
Cambridge, MA
Street
245 1st St, 18th Floor
Zip
02142

Offering

Total offering
$22.5M
Amount sold
$22.5M
First sale
Mar 11, 2026
Min investment
$0
Securities
Equity, Debt, Other
Federal exemption
Rule 506(b)
Investors so far
15

How this filing compares

Ranked #5 of 23 Biotech filings in March 2026 by offering amount.

Median Biotech filing in March 2026: $5.4M. This offering is 4.2× the median.

Other Massachusetts filings this week: Apnimed, Inc., BCV Emerge Fund V, L.P., LONG POINT INVESTORS, L.P., Neosoma, Inc., TA Realty Digital Real Estate Fund I, L.P.

Leadership

Jay Glenn Wohlgemuth — Executive Officer (also: Director)

Raymond Tabibiazar — Director

Fredric Neville Eshelman — Director

Frank Grazzini, II — Executive Officer

Filing details

Pacegenix, Inc. filed a Form D with the SEC on March 26, 2026.

Other newest Biotech companies

Other newest companies in Massachusetts